Heparinase from different sources can eliminate heparin or/and heparan sulfate into various low-molecular weight heparins with different characteristics. Porcine intestinal mucosa heparin was degraded into a series of oligosaccharides by a novel heparinase from the species Sphingobacterium. Disaccharide components from the digests were separated and purified by ultrafiltration and HPLC. Five major peaks appeared as three types according to their retention time. The mass spectrometry of peak I mainly gave the non-sulfated disaccharide with the mass of 379 Da. Peak II and III were indicated as two major monosulfated disaccharides with molecular mass of 417 and 459 Da respectively. Moreover, the peak III represented an Nacetyl disaccharide. Both peak IV and V showed the same mass of 496 Da, hinting that they were disulfatesubstituted disaccharides. No trisulfate-substituted disaccharides were detected in the mixture of the heparin digest though they were abundant in the heparin structure. The results revealed that the heparinase might specifically cut the sites with low sulfated domain in heparin.
Heparin like glycosaminoglycans (HLGAGs) are structurally complex linear polysaccharides composed of repeating disaccharide unit of uronic (α-L-iduronic or β-Dglucuronic) acid linked 1→4 to α-D-glucosamine, which is a highly variable sulfation pattern and ascribes to each glycosaminoglycan (GAG) chain a unique structural signature. This signature dictates specific the GAG-protein interactions underlying critical biological processes related to cell and tissue functions [1] . Only in few cases has the HLGAG sequence responsible for high affinity binding been elucidated by now although many proteins have been shown to bind HLGAGs with high affinity [2, 3] . This was mainly the difficulty to determine the sequences and structures of the HLGAGs themselves.
Attempts at sequencing and searching for the functional domains therefore have focused on oligosaccharide fragments obtained by HLGAG depolymerization [4] . Such fragments are generated either chemically or enzymatically. The enzymatic digestion shows advantages in that some of the functional domains in oligosaccharide may be maintained since the enzyme catalyzed reaction is mild and easy to control. Moreover, different heparinase shows different specificity [5, 6] . For example, heparinase I primarily cleaves HLGAGs at sites with an o-sulfated L-iduronic acid linkage (i.e., heparin-like regions); heparinase III requires primarily an unsulfated D-glucuronic acid moiety (heparan sulfate-like regions); heparinase II cleaves both heparin and heparan sulfate-like regions of HLGAGs [7] . Application of heparinases from other sources in the depolymerization of HLGAGs is still in investigation [8] [9] [10] .
We purified previously an endolytic heparinase from a novel species Sphingobacterium with some novel characteristics [11] . Substrate specificity test indicated that the enzyme had broad substrate specificity on both heparin and heparan sulfate. Primary tests also showed that the heparinase could produce larger oligosaccharide fragments with effective inhibition of the proliferation of smooth cells [12] .
To further investigate the catalytic mechanism of the heparinase, this paper focused on the separation of disaccharides from the digest of heparinase by HPLC and the characterization using ESI-MS technology.
Materials and Methods

Materials
Heparin (porcine intestinal mucosa) used for activity determination and cultivation of Sphingobacterium sp. was from Dongbao Biochemical Ltd. (Yantai, China). Standard I and II, the nonsulfated heparin disaccharide (α-δUA-[1→4]-GlcNAc) and the trisulfated heparin disaccharide (α-δUA-2S-[1→4]-GlcNS-6S) respectively, were purchased from Sigma. BSA was obtained from Shanghai Dongfeng Biochemical Ltd. (China). Other reagents were of either biological or analytical grade.
Heparinase used in this study was isolated and purified from Sphingobacterium sp. (GenBank accession No. AF492000) as described in reference [11] .
Preparation of heparin oligosaccharide mixture
10 IU heparinase was added to 400 ml of 20 mM sodium phosphate buffer (pH 7.4) containing 20 g of porcine mucosa heparin and BSA (at the final concentration of 1 mg/ml). After digestion at 30 °C with gentle shaking (absorbance at 232 nm attained about 0.4), the solution was kept at 100 °C for 1 min to end the reaction, and ultrafiltrated by using the MWCO 1 kD membrane at 4°C
. The filtrate was collected and desalted on the Sephadex G-10 column (1.6 cm×200 cm). The elute fractions, where the absorbance at 232 nm reached a peak, were pooled and concentrated by freeze-drying, then resolved in distilled water (pH 3.0) at the disaccharide concentration of about 100 mg/ml.
HPLC separation
SAX-HPLC separation of oligosaccharide mixture was performed on a 5-µm Spherisorb column (250 mm×10 mm) from Dalian Elite Ltd. (China). The mobile phase was water (solution A), and 2 M sodium chloride (solution B), with a linear gradient elution 0-0.3 M sodium chloride and a flow rate of 3.0 ml/min. The pH value of both solution A and B were adjusted to 3.0 by 2 M hydrochloric acid.
Identification of the purified oligosaccharides by ESImass spectrometry (ESI-MS)
ESI mass spectra were obtained using LCMS-2010 (Shimadzu, Japan). Mobile phase was methanol and the carrier is N 2 . The purified components were dissolved in 50% methanol (V/V).
Results and Discussion
Porcine intestinal mucosa heparin was subjected to exhausted depolymerization using the heparinase purified in our lab. Direct analysis of the depolymerization product on HPLC did not give obvious information of trisulfated disaccharide components (data not shown). Filtration using an MWCO 1 kD membrane mainly obtained the disaccharide fragments in the filtrate.
The filtrate was applied to SAX-HPLC for further purification. Five major peaks appeared during the elution, and were divided into three types according to the retention time (Fig. 1) . The retention time of each peak was summarized in Table 1 . Standard I and standard II represented the nonsulfated heparin disaccharide (α-δUA-[1→4]-GlcNAc) with one negative charge and the trisulfated heparin disaccharide with four negative charges (α-δUA-2S-[1→4]-GlcNS-6S) respectively. Retention time of heparin disaccharides fell between those of two disaccharide standards. Each peak was collected, desalted, concentrated and applied to the ESI-MS identification, Fig. 1 The profile of the disaccharide mixture on semipreparative SAX-HPLC respectively.
By ESI-MS analysis, characteristic peaks of the heparin disaccharide standard I and II were summarized in Table 2 , and the profile of standard II was shown in Fig. 2 . The mass peak of standard I was simple (m/z 378.2) (data not shown). Six mass peaks appeared for standard II indicating the complexity caused by the sulfation. Sodium cations exchanged with hydrogen protons in solution also caused the change of the mass peaks.
ESI-MS data for disaccharide components were summarized in Table 3 . Structures of the disaccharides represented by each peak were identified using ESI-MS in comparison with the disaccharide standard I and II. The ESI-MS data indicated that the structure of the peak I was the same as the standard I; peak II and peak III contained same charges but different mass and formula, showing that the later was an N-acetyl disaccharide. The ESI-MS characterization of peak III was shown in Fig. 3 . Peak IV and peak V showed the same mass spectrum (Fig. 4) , suggesting that they were probably the same formula but with different conformation.
In comparison with the disaccharide standards, one of the five deduced structures contained one nonsulfated disaccharide (Fig. 5, type I) . Peak II and III indicated two major monosulfated disaccharides with substitution of the sulfate at different site (Fig. 5, type II) . Peak IV and V Table 2 ESI-MS data of the two heparin disaccharide standards* were disulfated disaccharides (Fig. 5, type III) . The results were also justified by capillary electrophoresis (data not shown).
It was interesting that the disaccharide mixture prepared by the heparinase digest in this experiment did not contain the trisulfated disaccharide though it was common in the structure of heparin. The finding was significantly different from those of disaccharide compositions digested by the heparinase from other sources [13, 14] . Thus we can deduce that the heparinase eliminatively cut the bonds at the low-sulfate substituted sites in heparin chain, showing obvious endolytic catalysis. This characterization of the heparinase would be useful in investigation of heparin sequencing, searching for functional oligosaccharides in heparin for clinical purpose and preparation of low molecular weight heparin. Table 3 ESI-MS analysis of separated heparin disaccharides* 
